RPS29P23: A Promising Drug Target / Biomarker (G100271588)

Target Name: RPS29P23

NCBI ID: G100271588

RPS29P23

Other Name(s): Ribosomal protein S29 pseudogene 23 | ribosomal protein S29 pseudogene 23 | RPS29_17_1627

RPS29P23: A Promising Drug Target / Biomarker

The protein RPS29P23 is a key regulator of the production of platelets, which are critical for blood clotting and healing. Mutations in the Rps29P23 gene have been linked to a range of platelet disorders, including thrombosis, bleeding disorders, and anemia. As a result, the study of Rps29P23 has become an increasingly important area of research, with a focus on developing new treatments for these conditions.

The Structure of Rps29P23

Rps29P23 is a member of the P29 family of non-histone proteins, which play a critical role in the regulation of cell signaling pathways. The Rps29P23 protein has a molecular weight of approximately 48 kDa and consists of 29 amino acid residues. It has a distinct N-terminus, a middle transmembrane region, and an C-terminus that is involved in protein-protein interactions.

The N-terminus of Rps29P23 contains a putative N-endopeptide loop, which is involved in protein-protein interactions and may play a role in regulating the activity of the protein. The middle transmembrane region of Rps29P23 contains a series of conserved amino acids that are involved in the regulation of cell signaling pathways. The C-terminus of Rps29P23 contains a series of conserved amino acids that are involved in protein-protein interactions and may play a role in regulating the activity of the protein.

Expression and Function of Rps29P23

Rps29P23 is expressed in a variety of tissues and cells, including platelets, endothelial cells, and hematopoietic stem cells. It has been shown to play a critical role in the regulation of platelet production and function.

In addition to its role in platelet production, Rps29P23 has also been shown to play a critical role in the regulation of platelet function. Studies have shown that Rps29P23 is involved in the regulation of platelet aggregation and clot retraction, as well as the regulation of platelet integrity and stability.

Mutations in the Rps29P23 gene have been linked to a range of platelet disorders, including thrombosis, bleeding disorders, and anemia. For example, studies have shown that mutations in the Rps29P23 gene are associated with an increased risk of thrombosis and anemia, as well as decreased platelet aggregation and clot retraction.

Despite these promising findings, much more research is needed to fully understand the role of Rps29P23 in platelet biology and the development of new treatments for platelet disorders.

Conclusion

In conclusion, the protein Rps29P23 is a key regulator of the production of platelets and has been shown to play a critical role in the regulation of platelet function. Mutations in the Rps29P23 gene have been linked to a range of platelet disorders, including thrombosis, bleeding disorders, and anemia. Further research is needed to fully understand the role of Rps29P23 in platelet biology and the development of new treatments for platelet disorders.

Protein Name: Ribosomal Protein S29 Pseudogene 23

The "RPS29P23 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS29P23 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets